A new, healthy liver offers the best survival for patients with early-stage liver cancer. But a new study, led by Katie Ross-Driscoll, Ph.D., MPH, of Regenstrief Institute and Indiana University School of Medicine Department ...
Jun 10, 2024
0
0
Fibroblast activation protein (FAP)-targeted radioligand therapy is safe and effective for treating patients with progressive metastatic tumors, specifically advanced sarcomas, according to research presented at the 2024 ...
Jun 10, 2024
0
0
Despite rapidly rising rates of breast cancer in younger women and overwhelming evidence supporting the efficacy and cost-effectiveness of screening, the Canadian Task Force on Preventive Health Care has recommended against ...
Jun 5, 2024
0
0
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
0
Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening performance and reduced the rate of false-positive findings. Results of the study were published in Radiology.
Jun 4, 2024
0
1
Skin cancer is the most common cancer in the U.S., affecting millions worldwide. This cancer comes in two main types: melanoma, which is less common but more deadly, and non-melanoma skin cancers, which include basal cell ...
May 31, 2024
0
0
In contrast to traditional cancer treatments such as surgery, chemotherapy, and radiotherapy, photodynamic therapy (PDT) is emerging as a novel method that uses specific wavelengths of light to activate photosensitizers. ...
May 28, 2024
0
0
Hepatocellular carcinoma (HCC) represents a significant global health burden as one of the most common malignancies in individuals with chronic liver disease or cirrhosis. This malignancy evolves through a multistep process, ...
May 24, 2024
0
0
The number of mutations in the DNA of cancerous tumors may not be an indicator of how well patients will respond to immune checkpoint inhibitors (ICIs), a commonly prescribed type of immunotherapy, a team led by UT Southwestern ...
May 23, 2024
0
37
Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering ...
May 22, 2024
0
0
